Modeling transthyretin (TTR) amyloid diseases, from monomer to amyloid fibrils
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0304891 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Richard S Criddle und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, Brigham Young University, Provo, Utah, United States of America. Hauptthemen laut MEDLINE: Prealbumin, Amyloid. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Brigham Young University, NIH.
Abstract (Originalsprache)
ATTR amyloidosis is caused by deposition of large, insoluble aggregates (amyloid fibrils) of cross-β-sheet TTR protein molecules on the intercellular surfaces of tissues. The process of amyloid formation from monomeric TTR protein molecules to amyloid deposits has not been fully characterized and is therefore modeled in this paper. Two models are considered: 1) TTR monomers in the blood spontaneously fold into a β-sheet conformation, aggregate into short proto-fibrils that then circulate in the blood until they find a complementary tissue where the proto-fibrils accumulate to form the large, insoluble amyloid fibrils found in affected tissues. 2) TTR monomers in the native or β-sheet conformation circulate in the blood until they find a tissue binding site and deposit in the tissue or tissues forming amyloid deposits in situ . These models only differ on where the selection for β-sheet complementarity occurs, in the blood where wt-wt, wt-v, and v-v interactions determine selectivity, or on the tissue surface where tissue-wt and tissure-v interactions also determine selectivity. Statistical modeling in both cases thus involves selectivity in fibril aggregation and tissue binding. Because binding of protein molecules into fibrils and binding of fibrils to tissues occurs through multiple weak non-covalent bonds, strong complementarity between β-sheet molecules and between fibrils and tissues is required to explain the insolubility and tissue selectivity of ATTR amyloidosis. Observation of differing tissue selectivity and thence disease phenotypes from either pure wildtype TTR protein or a mix of wildtype and variant molecules in amyloid fibrils evidences the requirement for fibril-tissue complementarity. Understanding the process that forms fibrils and binds fibrils to tissues may lead to new possibilities for interrupting the process and preventing or curing ATTR amyloidosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, Brigham Young University, Provo, Utah, United States of America.
- Department of Statistics, Brigham Young University, Provo, Utah, United States of America.
ORCID-Profile: Lee D Hansen
Förderung
- NIGMS NIH HHS
- Brigham Young University
- NIH
Zitieren
APA
Criddle, R. S., Hansen, L. D., Woodfield, B. F., & Tolley, H. D. (2024). Modeling transthyretin (TTR) amyloid diseases, from monomer to amyloid fibrils. PLOS ONE. https://doi.org/10.1371/journal.pone.0304891
Vancouver
Criddle RS, Hansen LD, Woodfield BF, Tolley HD. Modeling transthyretin (TTR) amyloid diseases, from monomer to amyloid fibrils. PLOS ONE. 2024. doi:10.1371/journal.pone.0304891
BibTeX
@article{Criddle2024,
author = {Criddle, Richard S and Hansen, Lee D and Woodfield, Brian F and Tolley, H Dennis},
title = {Modeling transthyretin (TTR) amyloid diseases, from monomer to amyloid fibrils},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0304891}
}
EUVIMED